VIVO BIO TECH LTD Jobs: Explore Opportunities in Genetic Toxicology, Analytical Chemistry, and More
Embark on a transformative career journey with VIVO BIO TECH LTD, a pioneering Contract Research Organization (CRO) that stands at the forefront of drug discovery. Explore unique opportunities in Genetic Toxicology, Analytical Chemistry, Pathology, Toxicology, and Bioanalytical Chemistry Departments. Join our dynamic team and contribute to groundbreaking advancements in the pharmaceutical industry.
Introduction: At VIVO BIO TECH LTD, we believe in fostering innovation and pushing the boundaries of drug discovery. As we continue to make strides in the industry, we invite passionate and skilled professionals to join our diverse workforce. Fuel your ambition with a career that matters at VIVO BIO TECH LTD.
About VIVO BIO TECH LTD: VIVO BIO TECH LTD is more than just a company; it’s a dynamic force driving innovation in drug discovery. Established with a vision to redefine possibilities, VIVO BIO TECH LTD is a DSIR, CPCSEA, OECD GLP, and ISO certified organization. Our commitment to excellence and adherence to global standards make us a preferred partner in drug development.
📄 Get Your Dream Job with a Professional Resume!
💼 Struggling to Get Noticed by Recruiters? 📄 Let Professionally Crafted Resumes Boost Your Career! 🚀
📱 Get More DetailsVIVO BIO TECH LTD Vacancies List:
- Genetic Toxicology:
- Position: Study Director
- Experience: 5 to 7 years
- No. of Vacancies: 2
- Analytical Chemistry:
- Position: Study Director
- Experience: 4 to 7 years
- No. of Vacancies: 4
- Pathology:
- Position: Study Pathologist
- Experience: 2 to 4 years
- No. of Vacancies: 2
- Toxicology:
- Position: Study Director General Toxicology/Inhalation Toxicology
- Experience: 5 to 7 years
- No. of Vacancies: 6
- Bioanalytical Chemistry:
- Position: Study Director Bioanalysis
- Experience: 5 to 7 years
How to Apply: If you are ready to contribute to cutting-edge research and development, send your resume to hrd@vivobio.com or jobs@vivobio.com on or before March 20, 2024.
Responses